Fundraising Fox
/Companies
Sign in

Syncardia

Tucson, US · 1 known investors

Find your way into Syncardia

Sign up to see every warm intro you have to Syncardia

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Syncardia team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

SynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.

BiotechDeep TechHardwareHealthtechMedical Devices

Founders & leadership

JG
Jack G. Copeland, M.D.Co-founder
JG
Jack G. Copeland
RGRichard G. Smith
Richard G. Smith
MJMarvin J. Slepian
Marvin J. SlepianFounder at Picard Medical, Inc.
MGMichael Garippa
Michael GarippaExecutiveMichael Garippa held executive and board positions at multiple healthcare and medical device companies, including Syncardia and TandemHeart, and served as an independent director for a Costa Rican microfinance firm.
LB
Luis BurgosExecutive
DA
Douglas A. NutterExecutive
KC
Kirk CollamerChief Financial Officer2013–2015

Board

HG
Harry GeorgeBoard director
ES
Eric SalzmanBoard director
DD
Doug David FahouryBoard director
MC
Mark C. Goldberg, M.D.Board director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$6.4M disclosed across 1 round · 2014

▶$6.4MraisedOct 2014 · 83 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael GarippaExecutive Officer, Director
  • Doug David FahouryDirector
  • Mark C. Goldberg, M.D.Director
  • Jack G. Copeland, M.D.Director
  • Luis BurgosExecutive Officer
  • Douglas A. NutterExecutive Officer
  • Thomas K. CoxDirector
  • Harry GeorgeDirector
  • Kirk CollamerExecutive Officer
  • Eric SalzmanDirector
Offering amount
$15M
Amount sold
$6.4M
First sale
Sep 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Syncardia do?
SynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.
Who founded Syncardia?
Syncardia was founded by Jack G. Copeland, M.D., Jack G. Copeland, Richard G. Smith, Marvin J. Slepian.
Who are Syncardia's investors?
Syncardia's investors include Hunniwell Lake Ventures LLC.
How much funding has Syncardia raised?
Syncardia has disclosed $6.4M raised across 1 round.
Where is Syncardia headquartered?
Syncardia is headquartered in Tucson, US.